Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPLACE
2024-513822-53-00Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in tertiary adrenal insufficiency (TAI) comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Adrenal insufficiency symptoms (AddiQoL-30). Started Jul 2024; status: completed.
02
Drugs
hydrocortisone
03
Conditions
tertiary adrenal insufficiency (TAI)
Beyond the preview
Go deeper on 2024-513822-53-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513822-53-00.